Blog

Why Europe's heatwaves mean mosquito season is now your whole summer

Mosticare Editorial30 Jul 202610 min readEurope
a flooded street with a building and a dog lying on the ground
Shot by Wes Warren

The European Centre for Disease Prevention and Control has scaled up its warning this week: longer, hotter summers of continuously higher temperature create the conditions for mosquito-borne diseases to spread across Europe. The framing is not the single heatwave in the headlines. It is the season getting longer. That changes what a bedroom and a terrace in mainland Europe need to be, starting this summer and going forward. This piece sets out what the ECDC warning actually says, what it implies for West Nile virus, dengue and chikungunya, and the two complementary, chemical-free layers a household in Europe can put in place now: an untreated physical barrier over the bed at night, and an untreated mesh enclosure over the terrace in the evening.

On 29 July 2026 the European Centre for Disease Prevention and Control scaled up its warning on heatwaves and infectious disease in Europe. The message is precise and not the one most headlines carried. ECDC writes that while the current heatwaves make headlines, it is the continuously higher temperatures of an ever longer duration that create the conditions for many infections to spread. The framing is not the single heatwave. It is the season getting longer. Euronews reported the same warning the next day, noting that mosquito-borne diseases are becoming more common in Europe as longer warm and humid seasons allow invasive mosquitoes to thrive in regions where they were previously rare or entirely absent. The diseases ECDC names are dengue, chikungunya, and West Nile virus. The implications for a household in mainland Europe are not abstract. They are practical, and they begin with two rooms you use every day, the bedroom and the terrace.

What ECDC actually says, and what it does not say

The ECDC release points to four disease categories whose European geography is shifting with sustained heat: foodborne illness, waterborne Vibrio infections in coastal waters, tick-borne diseases (Lyme disease and tick-borne encephalitis), and mosquito-borne disease. The mosquito-borne piece is the one this article is about. ECDC does not predict an outbreak in any specific city, and we will not either. What ECDC does is name the mechanism: longer warm and humid seasons widen the calendar window during which invasive mosquito populations are active, and a wider activity window increases the cumulative probability of locally acquired transmission chains in receptive areas.

The supporting facts are well documented. The ECDC invasive mosquito maps (April 2026 update) record Aedes albopictus, the Asian tiger mosquito, as established in 369 regions across 16 European countries, up from 114 regions a decade earlier (ECDC, World Mosquito Day 2025 statement; ECDC invasive mosquito maps). The same update records a new introduction of Aedes aegypti in Luxembourg. The European Environment Agency's Climate-ADAPT indicator on climatic suitability for the tiger-mosquito season length, 1971 to 2099, shows the season-length suitability shifting northward and upward across the continent as mean summer temperatures rise. None of these facts is contested. They sit on the ECDC and EEA public surfaces.

What this changes for a West Nile virus season

West Nile virus is the mosquito-borne disease for which Europe has the longest surveillance track record. The 2026 European transmission season is now in its peak window. Euronews, reporting the ECDC statement, places the typical West Nile transmission season from late spring to autumn, peaking between July and September, with 2026 cases reported in Greece, Italy, North Macedonia, Romania, and Spain. The vector in Europe is primarily Culex pipiens, a different mosquito from the Asian tiger, and Culex is most active around dusk and into the night. This is the part of the day when people sit on the terrace or leave the bedroom window open to let warm air in. It is also the part of the day when Culex is feeding. The two rooms in your house where this matters most are the terrace in the evening and the bedroom through the night.

Dengue and chikungunya are different. The vector is Aedes albopictus, which is active during the day, with peaks at dawn and dusk. Aedes albopictus does not fly far. The adult flight range is around 100 metres from the larval habitat, which is small containers of stagnant water. The implication for the household is that the work begins at the perimeter of the house, not on a shelf at the pharmacy. Source reduction around the home is the most effective single measure the literature agrees on.

The bedroom: where the night cycle closes

The night cycle closes in the bedroom. In a European summer that no longer has a reliable cool window between midnight and dawn, windows stay open and ceiling fans run. That is exactly the environment in which Culex mosquitoes feed. The first layer of night-time protection is mechanical: an intact, untreated mesh screen on the window, the door, and any skylight. The second layer is over the bed itself: an untreated mosquito net, draped above the bed and tucked under the mattress, or a treated net if the household context places sleepers at higher cumulative risk.

Two distinctions matter here, and they are not marketing language. They are regulatory and chemical, and they constrain what we say about the products we make.

Treated bed nets (the families we manufacture for night-time sleep: Cubo Uno, Rondo Uno, Materasso Uno, Domo) are coated with permethrin. They are built to the specifications the World Health Organization publishes for long-lasting insecticidal nets and authorised under the EU Biocidal Products Regulation, Union authorisation EU-0026815-0000. The BPR authorisation covers insecticide-treated nets. It does not cover untreated mesh, gazebos, or untreated travel nets.

Untreated bed nets and untreated travel nets (Igloo, Volto, Igloo Bambino, the travel and pram untreated family) hold the mosquito away from the sleeper by exclusion alone, with nothing on the mesh. They do not carry a BPR statement because they are not biocidal products. We do not mix the two registers. The distinction exists because the products do different work, and because applying the language of one authorisation to the other category is factually wrong and legally fragile.

The practical decision is not 'treated or untreated' in the abstract. It is risk-proportionate. A household in a region where locally acquired West Nile, dengue, or chikungunya transmission has been documented this season, or where a household member is travelling to such a region, sits at higher cumulative risk and the treated option is the proportional choice. A household at lower cumulative risk sits at lower cumulative risk, and an untreated net does the mechanical work. Both layers belong on the bed.

The terrace: where the resurgence arrives first

The terrace is where the season arrives earliest in the evening. Aedes and Culex are both active around dusk, and European terraces from late June through September are exactly the setting for that activity window. An untreated mesh enclosure over the terrace turns the outdoor room into a screened room. There is no chemical involved. The mesh holds the mosquito out, and the people inside sit in still air rather than in citronella smoke.

For households across mainland Europe, the terrace protection layer is a structural choice rather than a daily routine. Once installed, an untreated mesh enclosure does its work every evening without reapplication, refilling, plugging in, or burning. This is the chemical-free answer the ECDC advice lines point at when they list 'window screens, mosquito nets, protective clothing' alongside repellent. The structural answer is the one that does not require a human to remember a step.

We are deliberate here. Our Terrazza gazebo is an untreated mesh enclosure. We make no WHO, BPR, or permethrin claim about it, because none applies. The product does its work by exclusion, and we describe it as such. The same goes for Igloo and Volto. The chemicals we use in our treated bed nets are not on any of these products. Anyone who tells you otherwise is either confused or selling you something else.

Source reduction: the layer that does not involve a purchase

Both ECDC and the public-health authorities of every country we work with list source reduction first. Once a week, empty the saucers under plant pots, clear the gutters, cover the water butts, store buckets and bins upside down, check the flat roof and the balcony for any standing water. The Aedes mosquito flies around 100 metres in its lifetime. If there is no container within that range holding water for more than a week, the local population cannot establish. This is the layer of the answer that has the largest single impact on the local mosquito population around a household, and it is the one that costs nothing.

What this piece does not promise

A mosquito net reduces bites and indoor entry. It does not prevent or cure disease. It is not a substitute for antimalarial prophylaxis, medical advice, or vaccination where vaccination is available. The West Nile virus fact sheet from the World Health Organization is explicit on this point. The dengue fact sheet from WHO is explicit on this point too. We say so in every piece we publish on protection, and we say so again here.

What a structural layer does, when it is in place before the season, is turn a daily scramble into a habit. That is what the ECDC framing of an ever longer duration is asking of European households. Not panic, not a new gadget every month, but a household that decides once which two rooms need to be sealed off from the mosquito, and then lives the season inside that decision. The bedroom and the terrace, the night and the evening. With the source-reduction routine, the structural mesh, and the proportional choice of treated or untreated for the bed, the ECDC warning becomes a manageable change in household routine rather than a forecast of dread.

Sources

Medical disclaimer

This article reports publicly stated assessments from the European Centre for Disease Prevention and Control, the European Environment Agency, the World Health Organization, and the cited peer-reviewed and primary-source literature. It does not replace personalised medical advice. In case of symptoms suggestive of dengue, chikungunya, or West Nile virus infection (sudden high fever, severe joint pain, neurological symptoms), consult a qualified clinician or contact the relevant national public-health authority. The mention of any specific product family by Mosticare is a description of how that product works, not a medical or preventive claim.

Sources & citations
  1. European Centre for Disease Prevention and Control, news release on sustained heatwaves and infectious-disease risk, 29 July 2026. The ECDC frames the current heatwaves as making headlines while the actual driver is 'continuously higher temperatures of an ever longer duration' that allow mosquito-borne, foodborne, waterborne and tick-borne infections to spread. Action: scaling up monitoring and cross-border One Health cooperation.
  2. Euronews, 30 July 2026: 'Europe's heatwaves are fuelling infectious diseases, health agency warns.' Reports the ECDC statement that mosquito-borne diseases are becoming more common in Europe because longer warm and humid seasons allow invasive mosquitoes to thrive where they were previously rare or absent. West Nile virus transmission season reported as running from late spring to autumn, peaking July to September, with 2026 cases in Greece, Italy, North Macedonia, Romania and Spain.
  3. ECDC factsheet, Aedes albopictus (Asian tiger mosquito): biology, daytime biting peaks, container-breeding habitat, flight range around 100 metres, and vector competence for dengue, chikungunya and Zika.
  4. ECDC, invasive mosquito maps (April 2026 update): Aedes albopictus established in 369 regions across 16 European countries, up from 114 regions a decade earlier. Aedes aegypti newly reported in Luxembourg.
  5. ECDC, World Mosquito Day 2025: Aedes albopictus established in 369 regions across 16 European countries, up from 114 regions a decade ago.
  6. European Environment Agency, Climate-ADAPT indicator: climatic suitability for the tiger-mosquito season length, 1971 to 2099. The season-length indicator shifts northward and upward as mean summer temperatures rise.
  7. World Health Organization, West Nile virus fact sheet: transmission primarily by Culex mosquitoes, mild febrile illness in about 20 percent of infections, neuroinvasive disease in under one percent, no vaccine for humans, prevention through mosquito-bite reduction.
  8. World Health Organization, dengue and severe dengue fact sheet: most infections are asymptomatic or self-limiting, severe dengue is a leading cause of serious illness and death in some countries, no specific antiviral treatment, prevention through vector control and personal protection.
  9. Commission Implementing Regulation (EU) 2022/2330: Union authorisation EU-0026815-0000 for permethrin used in insecticide-treated nets. Sits under the Biocidal Products Regulation and applies to treated nets only, not to untreated mesh, gazebos, or untreated travel nets.
  10. Regulation (EU) No 528/2012, the Biocidal Products Regulation (BPR): EU legal framework requiring authorisation for biocidal products, including permethrin-treated mosquito nets.
  11. Wikidata, Q15707648 (Aedes albopictus): open-entity identifier used for sameAs JSON-LD.

Correction policy: if any fact above is shown to be wrong, we will amend it in place with a dated correction notice. Contact corrections@mosticare.org.

Subscribe

Protecting humanity from the world's deadliest animal, honestly, scientifically, and without poisoning the people we serve.

Related